This opportunity funds infrastructure for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT), supporting clinical research sites conducting trials and biomarker validation studies for neurological disorders in adults and children. It fosters collaboration and expertise to accelerate safe and effective neurotherapeutic development through high-quality evidence generation.
Eligible applicants include a wide range of government entities, educational institutions, nonprofits, for-profit organizations, tribal governments, and other specified organizations. Potential applicants are encouraged to develop collaborations for clinical research site applications.
